Precious hours lysing adhesions in the operating room. Inadvertent damage to tissues and organs during reoperations. Readmissions for obstruction, infertility, and chronic pain…

Surgeons know the risks associated with adhesions--that’s why many of them rely on Seprafilm^® Adhesion Barrier. They have applied more than 800,000 sheets since its introduction. Seprafilm is a proven adhesion barrier. With clinical trials in both the abdomen and pelvis, no adhesion barrier has been studied more broadly than Seprafilm.^1,2

Learn effective techniques for placing Seprafilm View our site-specific placement videos to see proven techniques for handling Seprafilm and placing it throughout the peritoneal cavity.

		Hear what other surgeons have to say about adhesions and adhesion barriers Find out what surgeons say about adhesive disease and the impact of adhesion barriers on their practices.						Make sure Seprafilm gets to your operating room Do you want to tell a colleague about Seprafilm so it’s available in your OR? Would you like to speak to your local sales representative to learn more? Visit our I Want Seprafilm page to get started.

We’ve created Seprafilm.com to help provide you with information regarding the safety and efficacy of Seprafilm, helpful tips for using Seprafilm, and resources for discussing adhesions with your colleagues and patients. Of course, Genzyme representatives are also available to meet with health care professionals. To contact your Genzyme representative, please call Customer Care at the number listed on the right of this page.

Seprafilm^® Adhesion Barrier is indicated for the reduction of post-surgical adhesions in patients undergoing abdominal or pelvic laparotomy. The type and frequency of adverse events reported are consistent with events typically seen following surgery when used as directed. Seprafilm should not be wrapped around an intestinal anastomosis as such usage may result in increased anastomotic leak related events. For important safety information, please see the package insert.

1. Becker JM, Dayton MT, Fazio VW, et al. Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter study. J Am Coll Surg. 1996;183;297-306.

2. Diamond MP. Reduction of adhesions after uterine myomectomy by Seprafilm membrane (HAL-F): a blinded, prospective, randomized, multicenter clinical study. Fert Steril. 1996;66(6);904-910.